The role of TRPMLs in endolysosomal trafficking and function

Cell Calcium

Volumn 58, Issue 1, 2015, Pages 48-56

  Venkatachalam, Kartik ^a,b   Wong, Ching On ^a   Zhu, Michael X ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Autophagy; Ca2+; Endolysosomal; Endosomal; Late endosomal; Lysosomal; ML4; MLIV; Mucolipidosis type IV; Mucolipins; TRP channels; TRPML

Indexed keywords

FERROUS ION; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL MUCOLIPIN; UNCLASSIFIED DRUG; ZINC ION; CALCIUM;

AUTOPHAGOSOME; BIOPHYSICS; CELL FUNCTION; CELL MEMBRANE; CELL PH; CELL TRANSPORT; CELL VIABILITY; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CYTOPLASM VESICLE; ENDOSOME; EXOCYTOSIS; GENE; GENE INTERACTION; GENE MUTATION; HUMAN; INVERTEBRATE; LYSOSOME; LYSOSOME STORAGE DISEASE; MCOLN1 GENE; MITOCHONDRION; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE IV; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; VERTEBRATE; ANIMAL; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

CAENORHABDITIS ELEGANS; MAMMALIA;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CELL MEMBRANE; ENDOSOMES; HUMANS; LYSOSOMES; MITOCHONDRIA; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84930541540     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.10.008     Document Type: Review

References (140)

1. Venkatachalam K., Montell C. TRP channels. Annu. Rev. Biochem. 2007, 76:387-417.
2. Berman E.R., et al. Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J. Pediatr. 1974, 84(4):519-526.
3. Livni N., Legum C. Ultrastructure of cultured fibroblasts in mucolipidosis type IV. Exp. Cell Biol. 1976, 44(1):1-11.
4. Merin S., et al. The cornea in mucolipidosis IV. J. Pediatr. Ophthalmol. 1976, 13(5):289-295.
5. Tellez-Nagel I., et al. Mucolipidosis IV: clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch. Neurol. 1976, 33(12):828-835.
6. Livni N., Merin S. Mucolipidosis IV: ultrastructural diagnosis of a recently defined genetic disorder. Arch. Pathol. Lab. Med. 1978, 102(11):600-604.
7. Raas-Rothschild A., et al. Mucolipidosis type IV: the origin of the disease in the Ashkenazi Jewish population. Eur. J. Hum. Genet. 1999, 7(4):496-498.
8. Bargal R., et al. Identification of the gene causing mucolipidosis type IV. Nat. Genet. 2000, 26(1):118-123.
9. Bargal R., et al. Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population. Hum. Mutat. 2001, 17(5):397-402.
10. Bach G., et al. Mucopolysaccharide accumulation in cultured skin fibroblasts derived from patients with mucolipidosis IV. Am. J. Hum. Genet. 1977, 29(6):610-618.
11. Goldin E., et al. Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent. Pediatr. Res. 1995, 37(6):687-692.
12. Goebel H.H., Kohlschutter A., Lenard H.G. Morphologic and chemical biopsy findings in mucolipidosis IV. Clin. Neuropathol. 1982, 1(2):73-82.
13. Kohn G., et al. Mucolipidosis IV: prenatal diagnosis by electron microscopy. Prenat. Diagn. 1982, 2(4):301-307.
14. Bach G., Zeigler M., Kohn G. Biochemical investigations of cultured amniotic fluid cells in mucolipidosis type IV. Clin. Chim. Acta 1980, 106(2):121-128.
15. Crandall B.F., et al. Review article: mucolipidosis IV. Am. J. Med. Genet. 1982, 12(3):301-308.
16. Bargal R., Bach G. Phospholipids accumulation in mucolipidosis IV cultured fibroblasts. J. Inherit. Metab. Dis. 1988, 11(2):144-150.
17. Bargal R., Bach G. Phosphatidylcholine storage in mucolipidosis IV. Clin. Chim. Acta 1989, 181(2):167-174.
18. Bargal R., Bach G. Mucolipidosis type IV: abnormal transport of lipids to lysosomes. J. Inherit. Metab. Dis. 1997, 20(5):625-632.
19. Jansen S.M., et al. Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis. J. Inherit. Metab. Dis. 2001, 24(5):577-586.
20. Chen C.S., Bach G., Pagano R.E. Abnormal transport along the lysosomal pathway in mucolipidosis: type IV disease. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(11):6373-6378.
21. Pryor P.R., et al. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic 2006, 7(10):1388-1398.
22. Thompson E.G., et al. Lysosomal trafficking functions of mucolipin-1 in murine macrophages. BMC Cell Biol. 2007, 8:54.
23. Samie M.A., Xu H. Lysosomal exocytosis and lipid storage disorders. J. Lipid. Res. 2014, 55(6):995-1009.
24. Wakabayashi K., et al. Mucolipidosis type IV: an update. Mol. Genet. Metab. 2011, 104(3):206-213.
25. Zlotogora J., et al. A muscle disorder as presenting symptom in a child with mucolipidosis IV. Neuropediatrics 1983, 14(2):104-105.
26. Amir N., Zlotogora J., Bach G. Mucolipidosis type IV: clinical spectrum and natural history. Pediatrics 1987, 79(6):953-959.
27. Chitayat D., et al. Mucolipidosis type IV: clinical manifestations and natural history. Am. J. Med. Genet. 1991, 41(3):313-318.
28. Altarescu G., et al. The neurogenetics of mucolipidosis type IV. Neurology 2002, 59(3):306-313.
29. Frei K.P., et al. Mucolipidosis type IV: characteristic MRI findings. Neurology 1998, 51(2):565-569.
30. Folkerth R.D., et al. Mucolipidosis IV: morphology and histochemistry of an autopsy case. J. Neuropathol. Exp. Neurol. 1995, 54(2):154-164.
31. Casteels I., et al. Mucolipidosis type IV: presentation of a mild variant. Ophthalmic Paediatr. Genet. 1992, 13(4):205-210.
32. Reis S., et al. Mucolipidosis type IV: a mild form with late onset. Am. J. Med. Genet. 1993, 47(3):392-394.
33. Abraham F.A., et al. Retinal function in mucolipidosis IV. Ophthalmologica 1985, 191(4):210-214.
34. Riedel K.G., et al. Ocular abnormalities in mucolipidosis IV. Am. J. Ophthalmol. 1985, 99(2):125-136.
35. Newman N.J., et al. Corneal surface irregularities and episodic pain in a patient with mucolipidosis IV. Arch. Ophthalmol. 1990, 108(2):251-254.
36. Pradhan S.M., et al. Electronegative electroretinogram in mucolipidosis IV. Arch. Ophthalmol. 2002, 120(1):45-50.
37. Geer J.S., et al. Mucolipidosis type IV: a subtle pediatric neurodegenerative disorder. Pediatr. Neurol. 2010, 42(3):223-226.
38. Schiffmann R., et al. Constitutive achlorhydria in mucolipidosis type IV. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(3):1207-1212.
39. Lubensky I.A., et al. Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia. Am. J. Surg. Pathol. 1999, 23(12):1527-1531.
40. Slaugenhaupt S.A., et al. Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes. Am. J. Hum. Genet. 1999, 65(3):773-778.
41. Goldin E., et al. Mucolipidosis IV consists of one complementation group. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(15):8562-8566.
42. Bassi M.T., et al. Cloning of the gene encoding a novel integral membrane protein, mucolipidin - and identification of the two major founder mutations causing mucolipidosis type IV. Am. J. Hum. Genet. 2000, 67(5):1110-1120.
43. Sun M., et al. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 2000, 9(17):2471-2478.
44. Bach G. Mucolipidosis type IV. Mol. Genet. Metab. 2001, 73(3):197-203.
45. Acierno J.S., et al. A physical and transcript map of the MCOLN1 gene region on human chromosome 19p13.3-p13.2. Genomics 2001, 73(2):203-210.
46. Slaugenhaupt S.A. The molecular basis of mucolipidosis type IV. Curr. Mol. Med. 2002, 2(5):445-450.
47. Montell C. Physiology, phylogeny, and functions of the TRP superfamily of cation channels. Sci. STKE 2001, 2001(90):re1.
48. Benini A., et al. Characterization and expression analysis of mcoln1.1 and mcoln1.2: the putative zebrafish co-orthologs of the gene responsible for human mucolipidosis type IV. Int. J. Dev. Biol. 2013, 57(1):85-93.
49. Denis V., Cyert M.S. Internal Ca(2+) release in yeast is triggered by hypertonic shock and mediated by a TRP channel homologue. J. Cell Biol. 2002, 156(1):29-34.
50. Dong X.P., et al. PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome. Nat. Commun. 2010, 1:38.
51. Lima W.C., et al. Mucolipin controls lysosome exocytosis in Dictyostelium. J. Cell Sci. 2012, 125(Pt 9):2315-2322.
52. Fares H., Greenwald I. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat. Genet. 2001, 28(1):64-68.
53. Venkatachalam K., et al. Motor deficit in a Drosophila model of mucolipidosis type IV due to defective clearance of apoptotic cells. Cell 2008, 135(5):838-851.
54. Manzoni M., et al. Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization. FEBS Lett. 2004, 567(2-3):219-224.
55. Vergarajauregui S., Puertollano R. Two di-leucine motifs regulate trafficking of mucolipin-1 to lysosomes. Traffic 2006, 7(3):337-353.
56. Venkatachalam K., Hofmann T., Montell C. Lysosomal localization of TRPML3 depends on TRPML2 and the mucolipidosis-associated protein TRPML1. J. Biol. Chem. 2006, 281(25):17517-17527.
57. Miedel M.T., et al. Posttranslational cleavage and adaptor protein complex-dependent trafficking of mucolipin-1. J. Biol. Chem. 2006, 281(18):12751-12759.
58. Kim H.J., et al. Gain-of-function mutation in TRPML3 causes the mouse varitint-waddler phenotype. J. Biol. Chem. 2007, 282(50):36138-36142.
59. Xu H., et al. Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(46):18321-18326.
60. Grimm C., et al. A helix-breaking mutation in TRPML3 leads to constitutive activity underlying deafness in the varitint-waddler mouse. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(49):19583-19588.
61. Dong X.P., et al. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 2008, 455(7215):992-996.
62. Dong X.P., et al. Activating mutations of the TRPML1 channel revealed by proline-scanning mutagenesis. J. Biol. Chem. 2009, 284(46):32040-32052.
63. Wong C.O., et al. Drosophila TRPML is required for TORC1 activation. Curr. Biol. 2012, 22(17):1616-1621.
64. Song Y., et al. TRPML cation channels regulate the specialized lysosomal compartment of vertebrate B-lymphocytes. Eur. J. Cell Biol. 2006, 85(12):1253-1264.
65. Karacsonyi C., Miguel A.S., Puertollano R. Mucolipin-2 localizes to the Arf6-associated pathway and regulates recycling of GPI-APs. Traffic 2007, 8(10):1404-1414.
66. Martina J.A., Lelouvier B., Puertollano R. The calcium channel mucolipin-3 is a novel regulator of trafficking along the endosomal pathway. Traffic 2009, 10(8):1143-1156.
67. Kim H.J., et al. The Ca(2+) channel TRPML3 regulates membrane trafficking and autophagy. Traffic 2009, 10(8):1157-1167.
68. Zeevi D.A., et al. A potentially dynamic lysosomal role for the endogenous TRPML proteins. J. Pathol. 2009, 219(2):153-162.
69. Curcio-Morelli C., et al. Functional multimerization of mucolipin channel proteins. J. Cell. Physiol. 2010, 222(2):328-335.
70. Zeevi D.A., et al. Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy. J. Cell Sci. 2010, 123(Pt 18):3112-3124.
71. Samie M.A., et al. The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1. Pflugers Arch. 2009, 459(1):79-91.
72. 2+-dependent membrane trafficking in mucolipidosis IV. Biochem. Biophys. Res. Commun. 2004, 322(4):1384-1391.
73. LaPlante J.M., et al. Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett. 2002, 532(1-2):183-187.
74. Kiselyov K., et al. TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J. Biol. Chem. 2005, 280(52):43218-43223.
75. Soyombo A.A., et al. TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J. Biol. Chem. 2006, 281(11):7294-7301.
76. Raychowdhury M.K., et al. Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum. Mol. Genet. 2004, 13(6):617-627.
77. Vergarajauregui S., et al. Mucolipin 1 channel activity is regulated by protein kinase A-mediated phosphorylation. Biochem. J. 2008, 410(2):417-425.
78. Kim H.J., et al. A novel mode of TRPML3 regulation by extracytosolic pH absent in the varitint-waddler phenotype. EMBO J. 2008, 27(8):1197-1205.
79. Lev S., et al. Constitutive activity of the human TRPML2 channel induces cell degeneration. J. Biol. Chem. 2010, 285(4):2771-2782.
80. Grimm C., et al. Constitutive activity of TRPML2 and TRPML3 channels versus activation by low extracellular sodium and small molecules. J. Biol. Chem. 2012, 287(27):22701-22708.
81. Feng X., et al. Drosophila TRPML forms PI(3,5)P2-activated cation channels in both endolysosomes and plasma membrane. J. Biol. Chem. 2014, 289(7):4262-4272.
82. Chen C.C., et al. A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV. Nat. Commun. 2014, 5:4681.
83. Swetha M.G., et al. Lysosomal membrane protein composition: acidic pH and sterol content are regulated via a light-dependent pathway in metazoan cells. Traffic 2011, 12(8):1037-1055.
84. Cang C., et al. mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state. Cell 2013, 152(4):778-790.
85. Kukic I., et al. Zinc-dependent lysosomal enlargement in TRPML1-deficient cells involves MTF-1 transcription factor and ZnT4 (Slc30a4) transporter. Biochem. J. 2013, 451(2):155-163.
86. Zhang X., Li X., Xu H. Phosphoinositide isoforms determine compartment-specific ion channel activity. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(28):11384-11389.
87. Grimm C., et al. Small molecule activators of TRPML3. Chem. Biol. 2010, 17(2):135-148.
88. Shen D., et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat. Commun. 2012, 3:731.
89. Wang X., et al. TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes. Cell 2012, 151(2):372-383.
90. Feng X., et al. Drosophila TRPML Forms PI(3,5)P2-activated Cation Channels in Both Endolysosomes and Plasma Membrane. J Biol Chem 2014, 289(7):4262-4272.
91. Samie M., et al. A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev. Cell 2013, 26(5):511-524.
92. Hersh B.M., Hartwieg E., Horvitz H.R. The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(7):4355-4360.
93. Treusch S., et al. Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(13):4483-4488.
94. Mellman I., Fuchs R., Helenius A. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 1986, 55:663-700.
95. Calcraft P.J., et al. NAADP mobilizes calcium from acidic organelles through two-pore channels. Nature 2009, 459(7246):596-600.
96. 2+. J. Biol. Chem. 2010, 285(45):35039-35046.
97. Jha A., et al. Convergent regulation of the lysosomal two-pore channel-2 by Mg(2)(+): NAADP, PI(3,5)P(2) and multiple protein kinases. EMBO J. 2014, 33(5):501-511.
98. Patel S., Marchant J.S., Brailoiu E. Two-pore channels: regulation by NAADP and customized roles in triggering calcium signals. Cell Calcium 2010, 47(6):480-490.
99. Venugopal B., et al. Neurologic: gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am. J. Hum. Genet. 2007, 81(5):1070-1083.
100. 2+ channel TRPML1 in gastric acid secretion: based on analysis of knockout mice. Gastroenterology 2011, 140(3):857-867.
101. Micsenyi M.C., et al. Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV. J. Neuropathol. Exp. Neurol. 2009, 68(2):125-135.
102. Pryor P.R., et al. The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 2000, 149(5):1053-1062.
103. Venkatachalam K., Wong C.O., Montell C. Feast or famine: role of TRPML in preventing cellular amino acid starvation. Autophagy 2013, 9(1):98-100.
104. Kiselyov K., et al. TRPML: transporters of metals in lysosomes essential for cell survival?. Cell Calcium 2011, 50(3):288-294.
105. Schaheen L., Dang H., Fares H. Basis of lethality in C. elegans lacking CUP-5: the mucolipidosis type IV orthologue. Dev. Biol. 2006, 293(2):382-391.
106. Vergarajauregui S., et al. Autophagic dysfunction in mucolipidosis type IV patients. Hum. Mol. Genet. 2008, 17(17):2723-2737.
107. Curcio-Morelli C., et al. Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol. Dis. 2010, 40(2):370-377.
108. Miedel M.T., et al. Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis. J. Exp. Med. 2008, 205(6):1477-1490.
109. Luzio J.P., Bright N.A., Pryor P.R. The role of calcium and other ions in sorting and delivery in the late endocytic pathway. Biochem. Soc. Trans. 2007, 35(Pt 5):1088-1091.
110. Piper R.C., Luzio J.P. CUPpling calcium to lysosomal biogenesis. Trends Cell Biol. 2004, 14(9):471-473.
111. Campbell E.M., Fares H. Roles of CUP-5, the Caenorhabditis elegans orthologue of human TRPML1, in lysosome and gut granule biogenesis. BMC Cell Biol. 2010, 11:p40.
112. Nagata K., et al. The varitint-waddler (Va) deafness mutation in TRPML3 generates constitutive: inward rectifying currents and causes cell degeneration. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(1):353-358.
113. Lelouvier B., Puertollano R. Mucolipin-3 regulates luminal calcium, acidification, and membrane fusion in the endosomal pathway. J. Biol. Chem. 2011, 286(11):9826-9832.
114. Zoncu R., et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 2011, 334(6056):678-683.
115. Sancak Y., et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141(2):290-303.
116. Sancak Y., et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008, 320(5882):1496-1501.
117. Efeyan A., Zoncu R., Sabatini D.M. Amino acids and mTORC1: from lysosomes to disease. Trends Mol. Med. 2012, 18(9):524-533.
118. Yu L., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465(7300):942-946.
119. Zoncu R., Efeyan A., Sabatini D.M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 2011, 12(1):21-35.
120. Laplante J.M., et al. Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol. Genet. Metab. 2006, 89:339-348.
121. LaPlante J.M., et al. The cation channel mucolipin-1 is a bifunctional protein that facilitates membrane remodeling via its serine lipase domain. Exp. Cell Res. 2011, 317(6):691-705.
122. Sardiello M., et al. A gene network regulating lysosomal biogenesis and function. Science 2009, 325(5939):473-477.
123. Settembre C., et al. TFEB links autophagy to lysosomal biogenesis. Science 2011, 332(6036):1429-1433.
124. Medina D.L., et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell 2011, 21(3):421-430.
125. Terman A., Gustafsson B., Brunk U.T. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem. Biol. Interact. 2006, 163(1/2):29-37.
126. Terman A., Gustafsson B., Brunk U.T. Mitochondrial damage and intralysosomal degradation in cellular aging. Mol. Aspects Med. 2006, 27(5-6):471-482.
127. Spooner E., et al. Systematic screens for proteins that interact with the mucolipidosis type IV protein TRPML1. PLOS ONE 2013, 8(2):e56780.
128. Jennings J.J., et al. Mitochondrial aberrations in mucolipidosis type IV. J. Biol. Chem. 2006, 281(51):39041-39050.
129. Coblentz J., St Croix C., Kiselyov K. Loss of TRPML1 promotes production of reactive oxygen species: is oxidative damage a factor in mucolipidosis type IV?. Biochem. J. 2014, 457(2):361-368.
130. Di Palma F., et al. Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(23):14994-14999.
131. van Aken A.F., et al. TRPML3 mutations cause impaired mechano-electrical transduction and depolarization by an inward-rectifier cation current in auditory hair cells of varitint-waddler mice. J. Physiol. 2008, 586(Pt 22):5403-5418.
132. Colletti G.A., et al. Loss of lysosomal ion channel transient receptor potential channel mucolipin-1 (TRPML1) leads to cathepsin B-dependent apoptosis. J. Biol. Chem. 2012, 287(11):8082-8091.
133. Eichelsdoerfer J.L., et al. Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel. J. Biol. Chem. 2010, 285(45):34304-34308.
134. Spampanato C., et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol. Med. 2013, 5(5):691-706.
135. Bach G., Chen C.S., Pagano R.E. Elevated lysosomal pH in mucolipidosis type IV cells. Clin. Chim. Acta 1999, 280(1-2):173-179.
136. Kogot-Levin A., et al. Mucolipidosis type IV: the effect of increased lysosomal pH on the abnormal lysosomal storage. Pediatr. Res. 2009, 65(6):686-690.
137. Vergarajauregui S., Martina J.A., Puertollano R. LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV. J. Cell Sci. 2011, 124(Pt 3):459-468.
138. 2+-dependent interactor of mucolipin-1. J. Biol. Chem. 2009, 284(52):36357-36366.
139. Schaheen L., Patton G., Fares H. Suppression of the cup-5 mucolipidosis type IV-related lysosomal dysfunction by the inactivation of an ABC transporter in C. elegans. Development 2006, 133(19):3939-3948.
140. Bozzato A., Barlati S., Borsani G. Gene expression profiling of mucolipidosis type IV fibroblasts reveals deregulation of genes with relevant functions in lysosome physiology. Biochim. Biophys. Acta 2008, 1782(4):250-258.